Efficacy and Safety Of Glucagon-Like Peptide-1 Receptor Agonists For The Treatment of Type 2 Diabetes Mellitus: A Network Meta-Analysis
Version 2 2021-02-10, 17:44
Version 1 2021-02-10, 16:59
media
posted on 2021-02-10, 17:44 authored by Yawen Jiang, Jia Liu, Xin Chen, Weiping Jia, Jing WuArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
